(Q50891158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

T J A Dekker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

V T H B M Smit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

G K J Hooijer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

M J Van de Vijver

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

W E Mesker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

R A E M Tollenaar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

J W R Nortier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

4 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

931-937

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23211940%20AND%20SRC:MED&resulttype=core&format=json

Estimates of cancer incidence and mortality in Europe in 2008.

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Biopathologic profile of breast cancer core biopsy: is it always a valid method?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Can core biopsy be used instead of surgical biopsy in the diagnosis and prognostic factor analysis of breast carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Validation of tissue microarray technology in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599

Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS599